MABVAX THERAPEUTICS HLDGS IN's ticker is MBVXQ and the CUSIP is 55414P702. A total of 1 filers reported holding MABVAX THERAPEUTICS HLDGS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 8,903 | $4,000 | 0.04% |
| PANAGORA ASSET MANAGEMENT INC | 26,382 | $11,000 | 0.00% |